EMERYVILLE, Calif. (AP) _ Zogenix Inc. (ZGNX) on Thursday reported a loss of $23.5 million in its fourth quarter.
On a per-share basis, the Emeryville, California-based company said it had a loss of 95 cents. Losses, adjusted for one-time gains and costs, came to 73 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.
The drugmaker posted revenue of $11 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $5.1 million.
For the year, the company reported a loss of $69.7 million, or $2.81 per share, swinging to a loss in the period. Revenue was reported as $28.9 million.
Zogenix shares have declined 21 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.55, a fall of 4 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZGNX at https://www.zacks.com/ap/ZGNX
Keywords: Zogenix, Earnings Report